Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Greg Spendjian who wrote (692)	1/12/1998 4:37:00 PM
From: CIMA	Read Replies (3) \| Respond to of 14101

Spoke today with the broker who has the reputation in some circles as being a big mover and follower of DMX. He described this as a highly speculative stock. He likes the risk-reward consideration. He has used Pennsaid himself and says it works. He expects approval followed by major marketing next year. He sees EPS of $2-3 and a stock price of $20 to $40 assuming approval. Conversely, 50-70 cents without approval. He is in the stock as a long-term investor and the hot money traders are largely responsible for the price variations.